When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Pityriasis lichenoides

Last reviewed: 1 Feb 2026
Last updated: 10 Dec 2024

Summary

Definition

History and exam

Key diagnostic factors

  • acute to subacute recurrent skin eruption
  • polymorphic, generalized, nonpruritic skin eruption
Full details

Other diagnostic factors

  • scars or pigment changes
  • immunosuppression
  • recent illness
  • family history of pityriasis lichenoides
  • headache
  • myalgias/arthralgias
  • malaise
  • burning/pruritus
  • multiorgan failure
Full details

Risk factors

  • childhood to early adult age
  • male sex
  • HIV
Full details

Diagnostic tests

1st tests to order

  • dermoscopy
  • skin biopsy
Full details

Tests to consider

  • antistreptolysin titers
  • Epstein-Barr virus IgM/IgG viral capsid antigen and nuclear antigen antibody
  • monospot or heterophil antibody test
  • hepatitis B surface antigen, antisurface antibody, and anticore IgM
  • hepatitis C virus antibody
  • HIV screening
  • rapid plasma reagin
  • throat cultures
  • toxoplasma Sabin-Feldman dye test, indirect immunofluorescence/hemagglutination
  • erythrocyte sedimentation rate
  • CRP
  • serum LDH
  • WBC count
  • serum albumin
Full details

Treatment algorithm

ONGOING

mild to moderate disease

severe disease or treatment resistance

Contributors

Authors

Amy Musiek, MD

Professor of Dermatology

Division of Dermatology

Washington University School of Medicine in St. Louis

St. Louis

MO

Divulgaciones

AM is a paid lecturer in cutaneous T-cell lymphoma for Dermatology Week, is the author of the UpToDate article on Pityriasis lichenoides chronica, and is an investigator for multiple industry sponsored studies all unrelated to pityriasis lichenoides.

Agradecimientos

Dr Amy Musiek would like to gratefully acknowledge Dr Amer Khachemoune and Dr Marianna Blyumin-Karasik, previous contributors to this topic.

Divulgaciones

AK and MB-K declare that they have no competing interests.

Revisores por pares

Andrew D. Lee, MD

Resident

Department of Dermatology

Wake Forest University School of Medicine

Winston-Salem

NC

Divulgaciones

ADL declares that he has no competing interests.

Abdulhafez Selim, MD

Assistant Professor

King Fahd University of Petroleum and Minerals

Dhahran

Saudi Arabia

Divulgaciones

AS declares that he has no competing interests.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Khachemoune A, Blyumin ML. Pityriasis lichenoides: pathophysiology, classification, and treatment review. Am J Clin Dermatol. 2007;8(1):29-36. Resumen

Bowers S, Warshaw EM. Pityriasis lichenoides and its subtypes. J Am Acad Dermatol. 2006 Oct;55(4):557-72; quiz 573-6. Resumen

Bellinato F, Maurelli M, Gisondi P, et al. A systematic review of treatments for pityriasis lichenoides. J Eur Acad Dermatol Venereol. 2019 Nov;33(11):2039-49. Resumen

Jung F, Sibbald C, Bohdanowicz M, et al. Systematic review of the efficacies and adverse effects of treatments for pityriasis lichenoides. Br J Dermatol. 2020 Dec;183(6):1026-32. Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad